New Drugs and Therapeutics Update: Libre DUO® 10 Day Continuous Dual Glucose Ketone Monitoring System Prepared by Evan Graber, DO; Edited by Neha Patel, DO On…
Afrezza: Rapid-Acting Inhaled Insulin Approved for Children ≥ 6 Years Old with Diabetes Prepared on behalf of PES Drugs and Therapeutics Committee by Pranav Gupta, MD and edited…
New Meds and Tech from the D&T Committee: Teplizumab Approval Expanded to Stage 3 Type 1 Diabetes (Ages 8-17) Prepared on behalf of PES Drugs and Therapeutics Committee by…
New Meds and tech from D&T Committee: IMCIVREE® (setmelanotide) injection Prepared by Daniel Mak, MD; Edited by Neha Patel, DO On March 19, 2026, the FDA approved and…
New Drugs and Therapeutics Update: DESMODA™ (desmopressin acetate) Oral Solution Prepared by Daniel Mak, MD DESMODA® (desmopressin acetate) Oral Solution On February 25th, 2026, the FDA…
Mounjaro (tirzepatide) approved in Pediatrics Prepared on behalf of PES Drugs and Therapeutics Committee by, Evan Graber, DO, Emily Breidbart, MD, and Neha Patel, DO. Based on…
New Drugs and Therapeutics Update CRENESSITY (crinecerfont) capsules and oral solution On December 13, 2024, the FDA approved CRENESSITYTM (crinecerfont) as adjunctive treatment to glucocorticoid replacement…
New Device Announcement. The twiist™ Automated Insulin Delivery (AID) system has received clearance from FDA 510(k), although the launch date is unclear. This insulin pump has…
Generic Victoza® Teva pharmaceuticals launched a generic version of Victoza® (liraglutide injection 1.8mg ) The generic will cost $469.60 for a pack of two pens and…
In March 2023, the FDA extended the approval of Evinacumab (EVKEEZA©) to children 5-11 years with familial homozygous hypercholesteremia. Evinacumab had been previously approved for 12…